In a separate study, a patient with W66R mutation in COA6 was identified with neonatal hypertrophic cardiomyopathy, muscular hypotonia, and lactic acidosis and a clear COX defect in fibroblasts [53]. This evidence concerns the gene COX5A and hypertrophic cardiomyopathy.